Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eye; Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT04904120
What this trial is testing

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Who this might be right for
Melanoma (Skin)Melanoma Stage IVMelanoma, Uveal+1 more
Perspective Therapeutics 7
Not applicableLooking for participantsNCT07421739
What this trial is testing

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Who this might be right for
Choroidal MelanomaIndeterminate LesionsUveal Melanoma+1 more
Aura Biosciences 15
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Testing effectiveness (Phase 2)Looking for participantsNCT06121180
What this trial is testing

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Study completedNCT02158520
What this trial is testing

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
Academic and Community Cancer Research United 24
Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Not applicableLooking for participantsNCT05797415
What this trial is testing

Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers

Who this might be right for
Ocular Sebaceous CarcinomaOcular Basal Cell CarcinomaOcular Surface Squamous Neoplasia+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 25
Large-scale testing (Phase 3)Ended earlyNCT00110123
What this trial is testing

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Who this might be right for
Intraocular MelanomaMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)UnknownNCT05077280
What this trial is testing

Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
California Pacific Medical Center Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT02517736
What this trial is testing

Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination

Who this might be right for
Uveal Melanoma
University Hospital, Caen 32
Testing effectiveness (Phase 2)Ended earlyNCT02359851
What this trial is testing

Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Who this might be right for
Stage IIIA Uveal MelanomaStage IIIB Uveal MelanomaStage IIIC Uveal Melanoma+1 more
Vanderbilt-Ingram Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT01252251
What this trial is testing

RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680
What this trial is testing

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more
M.D. Anderson Cancer Center 50
Not applicableEnded earlyNCT02336763
What this trial is testing

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more
Jonsson Comprehensive Cancer Center 2
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00344799
What this trial is testing

Cytogenetic Study of Ocular Melanoma

Who this might be right for
Choroidal Melanoma
Jonsson Comprehensive Cancer Center 95
Testing effectiveness (Phase 2)Study completedNCT02129075
What this trial is testing

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

Who this might be right for
Cutaneous MelanomaMelanomaMelanoma of Unknown Primary+9 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT05169957
What this trial is testing

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Who this might be right for
Melanoma, OcularMelanoma, CutaneousMetastatic Melanoma+2 more
University of Michigan Rogel Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00072345
What this trial is testing

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Next Page